
    
      Patients undergoing nephrectomy procedures will be allocated to one of the study arms. At the
      end of an operation, still under general anesthesia, 50% patients will obtain QLB with
      ropivacaine.

      Ultrasound-guided QLB will be performed on the side of surgery with 0.375% ropivacaine
      solution (0.2 mL per kg).

      Every patient will get patient-controlled analgesia pump with oxycodone in the postoperative
      period.

      Postoperative pain will be measured with VAS (visual-analogue scale) 2, 4, 8, 12 and 24 hours
      after the end of the operation. 24 -hours period.

      At the 1, 3, 6 months patients will be interviewed by phone to assess neuropathic pain.
      Neuropathic Pain Symptom Inventory (NPSI) will be used.
    
  